If nausea persists beyond week 6, inform your PlexusDx cliniciandose adjustment or a switch to oral semaglutide may ease the transition
The STEP trials for semaglutide 2.4 mg (Wegovy) showed: Average weight loss of approximately 15% of body weight over 68 weeks One-third of participants lost 20% or more of body weight Significant reductions in waist circumference, blood pressure, and cardiovascular risk markers The SURMOUNT trials for tirzepatide (Zepbound) showed even more impressive results: Average weight loss of 20-25% at the highest dose (15 mg) over 72 weeks More than half of participants lost 20% or more of body weight Significant improvements in type 2 diabetes markers, blood pressure, and lipid profiles The head-to-head comparison is clear
Injection site selection balances convenience with proximity to target tissues
We also added in our Steep Me Medicinal Mushrooms
References: [1] pmc/articles/PMC6271067/ [2] science/article/abs/pii/S00219673 12014550 [3] United Kingdom TB500 & BPC-157 Blend Nasal Spray Specifications: BPC-157: Sequence : Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ma Asp-Asp Ala Gly Leu Val Molecular Formula: C62H98N16O22 Molecular Weight: 1419.556 Explore our complete range of BPC-157 products here
care delivery systems from 2014 to 2022, American Indian/Alaska Native, Asian, Black, Hawaiian or Pacific Islander, and Hispanic individuals were less likely to be prescribed a GLP-1 than White individuals [238]